ArticleMethods in molecular biology (Clifton, N.J.)2025
BioID in Bacteria: Selection of a Suitable Biotin Ligase for Proxeome Mapping.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the initial use of BirA* for proximity-dependent biotin identification (BioID), researchers have explored variations of, and alternatives to, this specific biotin ligase enzyme. The application of these biotin ligase modules across diverse model systems has shown advancements in biotinylation efficiency and reduced labeling time. However, these improvements have also introduced challenges, such as increased background labeling. Bacterial BioID, a relatively recent development, is currently limited to studying bait proteins using miniTurbo- and TurboID-based fusions. So far, a comprehensive comparative analysis of the various promiscuous biotin ligases (PBLs) has been reported for only one bacterial species. In this chapter, we present a practical guide for selecting the most effective PBL tailored to the specific requirements of the bait and its corresponding model system for BioID-based interactome mapping in bacteria. Using the Salmonella enterica serovar Typhimurium type III effector protein SopB as a case study, we highlight a pioneering exploration of endogenous effector interactions directly within bacterial cells.
Indexed as
Identifiers
40638039What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.